Integer Holdings Corporation (ITGR)
USD 131.5
(-3.79%)
USD 131.5
(-3.79%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 167.33 Million USD | 37.92% |
| 2022 | 121.32 Million USD | -10.6% |
| 2021 | 135.71 Million USD | 12.52% |
| 2020 | 120.61 Million USD | -23.49% |
| 2019 | 157.63 Million USD | 1.34% |
| 2018 | 155.55 Million USD | 11.56% |
| 2017 | 139.43 Million USD | 28.79% |
| 2016 | 108.27 Million USD | 723.6% |
| 2015 | 13.14 Million USD | -82.62% |
| 2014 | 75.65 Million USD | 23.34% |
| 2013 | 61.33 Million USD | 137.55% |
| 2012 | 25.82 Million USD | -58.15% |
| 2011 | 61.69 Million USD | -10.57% |
| 2010 | 68.99 Million USD | 6483.4% |
| 2009 | 1.04 Million USD | -97.0% |
| 2008 | 34.89 Million USD | 74.3% |
| 2007 | 20.02 Million USD | -10.53% |
| 2006 | 22.37 Million USD | 32.51% |
| 2005 | 16.88 Million USD | -37.32% |
| 2004 | 26.94 Million USD | -29.48% |
| 2003 | 38.2 Million USD | 43.26% |
| 2002 | 26.66 Million USD | 19.12% |
| 2001 | 22.38 Million USD | 55.44% |
| 2000 | 14.4 Million USD | 15.67% |
| 1999 | 12.44 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 46.6 Million USD | 7.12% |
| 2024 Q2 | 60.7 Million USD | 30.24% |
| 2024 Q3 | 58.01 Million USD | -4.43% |
| 2023 Q3 | 48.07 Million USD | 15.63% |
| 2023 FY | 167.33 Million USD | 37.92% |
| 2023 Q4 | 43.51 Million USD | -9.49% |
| 2023 Q1 | 34.16 Million USD | 93.75% |
| 2023 Q2 | 41.57 Million USD | 21.69% |
| 2022 Q1 | 22.49 Million USD | -21.51% |
| 2022 FY | 121.32 Million USD | -10.6% |
| 2022 Q4 | 17.63 Million USD | -39.73% |
| 2022 Q3 | 29.25 Million USD | -10.55% |
| 2022 Q2 | 32.7 Million USD | 45.38% |
| 2021 FY | 135.71 Million USD | 12.52% |
| 2021 Q3 | 33.09 Million USD | -15.91% |
| 2021 Q4 | 28.66 Million USD | -13.38% |
| 2021 Q1 | 34.6 Million USD | 25.42% |
| 2021 Q2 | 39.35 Million USD | 13.7% |
| 2020 Q4 | 27.59 Million USD | -30.6% |
| 2020 Q2 | 9.18 Million USD | -79.16% |
| 2020 Q1 | 44.07 Million USD | 94.61% |
| 2020 FY | 120.61 Million USD | -23.49% |
| 2020 Q3 | 39.75 Million USD | 332.86% |
| 2019 Q1 | 39.16 Million USD | -1.33% |
| 2019 Q4 | 22.64 Million USD | -51.27% |
| 2019 Q2 | 49.33 Million USD | 25.96% |
| 2019 Q3 | 46.48 Million USD | -5.79% |
| 2019 FY | 157.63 Million USD | 1.34% |
| 2018 FY | 155.55 Million USD | 11.56% |
| 2018 Q4 | 39.69 Million USD | -4.25% |
| 2018 Q3 | 41.45 Million USD | -6.54% |
| 2018 Q2 | 44.35 Million USD | 27.77% |
| 2018 Q1 | 34.71 Million USD | 0.56% |
| 2017 Q2 | 39.73 Million USD | 49.7% |
| 2017 Q3 | 38.63 Million USD | -2.79% |
| 2017 Q4 | 34.52 Million USD | -10.63% |
| 2017 FY | 139.43 Million USD | 28.79% |
| 2017 Q1 | 26.54 Million USD | -14.38% |
| 2016 FY | 108.27 Million USD | 723.6% |
| 2016 Q1 | 11.13 Million USD | 206.32% |
| 2016 Q2 | 29.26 Million USD | 162.88% |
| 2016 Q3 | 36.86 Million USD | 25.94% |
| 2016 Q4 | 31 Million USD | -15.89% |
| 2015 Q3 | 1.19 Million USD | -90.83% |
| 2015 Q1 | 9.38 Million USD | -46.07% |
| 2015 Q4 | -10.47 Million USD | -976.32% |
| 2015 FY | 13.14 Million USD | -82.62% |
| 2015 Q2 | 13.03 Million USD | 38.82% |
| 2014 Q3 | 16.18 Million USD | -17.18% |
| 2014 Q2 | 19.53 Million USD | -13.25% |
| 2014 Q1 | 22.52 Million USD | 75.11% |
| 2014 FY | 75.65 Million USD | 23.34% |
| 2014 Q4 | 17.4 Million USD | 7.57% |
| 2013 Q3 | 17 Million USD | -0.78% |
| 2013 FY | 61.33 Million USD | 137.55% |
| 2013 Q4 | 12.86 Million USD | -24.34% |
| 2013 Q2 | 17.13 Million USD | 19.5% |
| 2013 Q1 | 14.33 Million USD | 920.57% |
| 2012 Q3 | 2.12 Million USD | -80.82% |
| 2012 FY | 25.82 Million USD | -58.15% |
| 2012 Q2 | 11.09 Million USD | -0.96% |
| 2012 Q1 | 11.19 Million USD | -10.72% |
| 2012 Q4 | 1.4 Million USD | -33.94% |
| 2011 Q3 | 12.88 Million USD | -29.59% |
| 2011 FY | 61.69 Million USD | -10.57% |
| 2011 Q4 | 12.54 Million USD | -2.68% |
| 2011 Q2 | 18.3 Million USD | 1.88% |
| 2011 Q1 | 17.96 Million USD | -26.71% |
| 2010 FY | 68.99 Million USD | 6483.4% |
| 2010 Q2 | 17.31 Million USD | 23.73% |
| 2010 Q1 | 13.99 Million USD | 711.98% |
| 2010 Q4 | 24.51 Million USD | 86.13% |
| 2010 Q3 | 13.16 Million USD | -23.95% |
| 2009 Q3 | -23.93 Million USD | -291.94% |
| 2009 FY | 1.04 Million USD | -97.0% |
| 2009 Q4 | -2.28 Million USD | 90.44% |
| 2009 Q2 | 12.46 Million USD | -15.74% |
| 2009 Q1 | 14.79 Million USD | 23.65% |
| 2008 Q4 | 11.96 Million USD | -23.84% |
| 2008 Q3 | 15.71 Million USD | 38.42% |
| 2008 Q2 | 11.35 Million USD | 374.2% |
| 2008 Q1 | -4.14 Million USD | -176.31% |
| 2008 FY | 34.89 Million USD | 74.3% |
| 2007 Q1 | 10.6 Million USD | 836.93% |
| 2007 Q2 | -6.35 Million USD | -159.88% |
| 2007 Q3 | 10.34 Million USD | 262.81% |
| 2007 Q4 | 5.42 Million USD | -47.53% |
| 2007 FY | 20.02 Million USD | -10.53% |
| 2006 FY | 22.37 Million USD | 32.51% |
| 2006 Q4 | 1.13 Million USD | -72.15% |
| 2006 Q3 | 4.06 Million USD | -42.96% |
| 2006 Q1 | 10.05 Million USD | 765.81% |
| 2006 Q2 | 7.12 Million USD | -29.1% |
| 2005 FY | 16.88 Million USD | -37.32% |
| 2005 Q4 | 1.16 Million USD | -18.75% |
| 2005 Q3 | 1.42 Million USD | -82.19% |
| 2005 Q2 | 8.02 Million USD | 27.86% |
| 2005 Q1 | 6.27 Million USD | 59.0% |
| 2004 FY | 26.94 Million USD | -29.48% |
| 2004 Q3 | 4.91 Million USD | -36.26% |
| 2004 Q4 | 3.94 Million USD | -19.68% |
| 2004 Q2 | 7.7 Million USD | -25.69% |
| 2004 Q1 | 10.37 Million USD | 45.57% |
| 2003 Q1 | 9.74 Million USD | 13.38% |
| 2003 FY | 38.2 Million USD | 43.26% |
| 2003 Q4 | 7.12 Million USD | -39.51% |
| 2003 Q3 | 11.78 Million USD | 23.41% |
| 2003 Q2 | 9.54 Million USD | -2.06% |
| 2002 Q2 | 5.96 Million USD | 3.7% |
| 2002 Q1 | 5.75 Million USD | 5.83% |
| 2002 FY | 26.66 Million USD | 19.12% |
| 2002 Q4 | 8.59 Million USD | 35.56% |
| 2002 Q3 | 6.34 Million USD | 6.25% |
| 2001 Q1 | 5.4 Million USD | 6.69% |
| 2001 FY | 22.38 Million USD | 55.44% |
| 2001 Q2 | 4.99 Million USD | -7.61% |
| 2001 Q3 | 6.54 Million USD | 31.12% |
| 2001 Q4 | 5.43 Million USD | -16.92% |
| 2000 Q3 | 2.58 Million USD | 0.0% |
| 2000 Q4 | 5.06 Million USD | 96.24% |
| 2000 FY | 14.4 Million USD | 15.67% |
| 1999 FY | 12.44 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 97.417% |
| Allurion Technologies Inc. | -78.07 Million USD | 314.311% |
| Artivion, Inc. | 5.74 Million USD | -2814.141% |
| Avanos Medical, Inc. | 4.2 Million USD | -3884.048% |
| Butterfly Network, Inc. | -145.61 Million USD | 214.917% |
| Butterfly Network, Inc. | -145.61 Million USD | 214.917% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | 56.401% |
| Boston Scientific Corporation | 2.34 Billion USD | 92.858% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | 1202.16% |
| CONMED Corporation | 130.78 Million USD | -27.942% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 89.093% |
| Paragon 28, Inc. | -37.3 Million USD | 548.498% |
| Glaukos Corporation | -128.7 Million USD | 230.016% |
| Globus Medical, Inc. | 133.14 Million USD | -25.678% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | 515.51% |
| Medtronic plc | 5.14 Billion USD | 96.747% |
| Nevro Corp. | -99.3 Million USD | 268.496% |
| Owlet, Inc. | -28.63 Million USD | 684.416% |
| Penumbra, Inc. | 73.55 Million USD | -127.502% |
| Vicarious Surgical Inc. | -80.66 Million USD | 307.436% |
| Smith & Nephew plc | 425 Million USD | 60.628% |
| Sonendo, Inc. | -57.74 Million USD | 389.784% |
| STERIS plc | 836.11 Million USD | 79.987% |
| Stryker Corporation | 3.88 Billion USD | 95.696% |
| Vapotherm, Inc. | -39.08 Million USD | 528.173% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 86.904% |